Fig. 1: Study consort diagram.
From: Clinico-pathological factors predicting pathological response in early triple-negative breast cancer
TNBC triple-negative breast cancer, NACi neoadjuvant chemoimmunotherapy.
Fig. 1: Study consort diagram. | npj Breast Cancer
